The Features of the Formation of Antibiotic Resistance in the Causative Agents of Pyo-Inflammatory Lung Diseases

Objective: to study the features of the formation of antibacterial resistance of the causative agents of pyo-inflammatory lung diseases. Material and methods. The microbiological landscape of 59 patients with severe forms of pneumonia, the ability of the isolates to form biofilms, and the presence of the resistance genes to carbapenems and cephalosporins have been studied. Results. 73 isolates were isolated by the microbiological method. K. pneumoniae was the most common (64.4%). The microflora was not detected in 5 cases. The use of the PCR diagnostics made it possible to identify the associations of microorganisms in all the cases. P. aeruginosa was the one which formed the biofilm most intensively. The most common resistance genes were OXA-48 (63.1 %), CTX-M (35.9 %), and NDM (25 %). Conclusion. K. pneumoniae having the OXA-48 resistance gene was the most common pathogen in the patients with severe forms of pneumonia in the Resuscitation and Intensive Care Ward of Vitebsk Regional Clinical Hospital. The majority of the isolates possessed a moderate or high ability to form the biofilm with its maximum weight in P. aeruginosa 136.5 [23; 75.1] µg/well. The detection of antibiotic resistance genes by the method of the PCR diagnostics will make it possible to adjust the choice of drugs.

microorganisms, biofilm, pneumonia, PCR diagnostics, resistance genes

1. Чучалин АГ. Плевра: патофизиологические и клинические аспекты. Пульмонология. 1999: 1: 6 10.

2. Бисенков ЛН, Бебия НВ, Гришаков СВ, Железный ОГ, Замятин МН [и др.]. Торакальная хирургия. Санкт-Петербург, РФ: Гиппократ, 2004. 1918 с.

3. Вишневский АА, Маршак АМ, Кашин ЮД. Лечение анаэробных плевропульмональных заболеваний. Вестник хирургии. 1980: 2: 19-21.

4. Гостищев ВК, Смоляр ВА, Афанасьев АН, Шевченко ЮЛ. Дифференцированный подход к комплексному лечению больных с абсцессами и гангреной легких: документы, представленные на Третьем конгрессе ассоциации хирургов им. Н.И. Пирогова. Москва: М.; 2002.

5. Лаптев АН. Гнойно-некротические деструкции легких. Медицинская панорама. 2008: 13: 21-26.

6. Palmer RJ, Stoodley J. Biofilms 2007: broadened horizons and new emphases. J. Bacteriol. 2007:189 (22): 7948-7960.

7. Davey ME. Microbial biofilms: from ecology to molecular genetics. Microbiol. Mol. Biol. Rev. 2000: 64: 847-867.

8. Чеботарь ИВ, Погорелов АГ, Яшин ВА. Современные технологии исследования бактериальных биопленок. Современные технологии в медицине. 2013: 5(1): 14-20.

9. Donlan RM. Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms. CLIN. MIC. REV. 2002: 15 (2): 167-193.

10. Stewart PS. Antibiotic resistance of bacteria in biofilms. Lancet. 2001: 358: 135-138.

11. Лопухов ЛВ, Эйдельштейн МВ. Полимеразная цепная реакция в клинической микробиологической диагностике. Клиническая микробиология и антимикробная химиотерапия. 2000; 4(2):URL96-106http://www.antibiotic.ru/cmac/2000_2_3/096.htm.

12. Окулич ВК, Кабанова АА, Плотников ФВ. Микробные биопленки в клинической микробиологии и антибактериальной терапии. Витебск. 2017: 300.http://elib.vsmu.by/handle/123/12846.